News

News (2016)

December, 2016 (11) November, 2016 (12) October, 2016 (12) September, 2016 (8) August, 2016 (12) July, 2016 (19) June, 2016 (9) May, 2016 (21) April, 2016 (13)
  • 29 April, 2016

    Jamison_135x132

    Day of Immunology

    Burnet Institute has celebrated the 2016 Day of Immunology by opening our laboratory doors to offer new insights into our immunological research.

  • 25 April, 2016

    Beesonamrep_135x132

    The quest for a malaria vaccine

    On World Malaria Day, Professor James Beeson writes on the importance of continuing the quest for a malaria vaccine.

  • 23 April, 2016

    Bryce_135x132

    Spotlight on HMHB in Brisbane

    Corporate, government and health policy leaders from Queensland have thrown their support behind Burnet’s Healthy Mothers, Healthy Babies program.

  • 21 April, 2016

    Mouhandshake_135x132

    Burnet, University of PNG forge new ties

    Burnet and the the University of Papua New Guinea (UPNG) are set to benefit from a new collaborative partnership.

  • 20 April, 2016

    Crabbthornton_135x132

    HMHB attracts Principal Supporter

    Burnet’s Healthy Mothers, Healthy Babies program has a new Principal Supporter in Bank South Pacific.

  • 18 April, 2016

    Beeson_135x132

    Rebound warning at malaria symposium

    Burnet’s Professor James Beeson tells a symposium malaria will rebound if the gains achieved are taken for granted.

  • 15 April, 2016

    Mosquito_135x132

    Breakthrough antimalarial study

    Dr Paul Gilson excited by research suggesting that resistance to the antimalarial Atovaquone can’t spread to the general human population.

  • 15 April, 2016

    Csl_135x132

    CSL launches $25m fellowship program

    CSL has announced the establishment of a new $25 million fellowship program for early stage and translational research.

  • 13 April, 2016

    Shan_135x132

    Burnet hosts Nanjing delegation

    Burnet Institute has hosted a high-level delegation from Nanjing in China for discussions on the potential expansion of Burnet’s R&D facilities in Nanjing.

  • 07 April, 2016

    Gov_135x132

    Burnet's viceregal celebration

    Burnet Institute’s 30th anniversary year has been acknowledged and celebrated at a reception hosted by Burnet’s Patron-in-Chief.

  • 06 April, 2016

    Presentation_135x132

    Budding scientists tour Burnet laboratories

    A group of 11-year-old friends with a keen interest in infectious diseases has enjoyed a tour of Burnet’s laboratories.

  • 05 April, 2016

    Mrff-135x132

    Burnet welcomes MRFF milestone

    The announcement of the expert advisory board is an important step for the Medical Research Future Fund (MRFF) says Professor Brendan Crabb.

  • 04 April, 2016

    Ladypotter_135x132

    Lady Potter a Burnet Patron

    Burnet Institute is pleased to announce the appointment of Lady Primrose Potter AC as a Patron of the Institute.

March, 2016 (11) February, 2016 (14) January, 2016 (6)
  • 27 January, 2016

    Mariamyerspng_135x132

    Maria Myers AC

    Burnet Institute Patron Mrs Maria Myers named a Companion in the Order of Australia (AC) in the 2016 Australia Day Honours.

  • 18 January, 2016

    Midsumma_thumbnail

    Burnet celebrates Midsumma

    More than 100,000 people came to Alexandra Gardens for the 2016 Midsumma Carnival.

  • 15 January, 2016

    Listening_135x132

    Burnet hosts Vietnam MoH delegation

    Burnet Institute has hosted a delegation of senior administrators from the Ministry of Health in Vietnam.

  • 05 January, 2016

    Sexting

    World-first project seeks funding

    Donations needed to create an online guide to teach young people about pornography and sexting to reduce potential harms.

  • 04 January, 2016

    Square_mark_stoove_headshot_210x210

    Is Myanmar ready for PrEP?

    Research has revealed that if PrEP were available in Myanmar, a large proportion of at-risk HIV-negative men would be willing to take it.

  • 04 January, 2016

    Tap_tn

    TAP Study: A key to hepatitis C elimination

    Burnet’s Treatment and Prevention Study targets those at greatest risk of HCV, people who inject drugs.

Subscribe to News

Subscribe to receive our latest news: